Hinckley release: Mental illness, not a gun, almost cost us

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Hinckley release: Mental illness, not a gun, almost cost us Reagan's life

John Hinckley, Jr., now 61, the man who attempted to assassinate President Reagan, is being freed from a psychiatric hospital to live full-time with his mother in Virginia. The word came through a federal court order by U.S. District Judge Paul L. Friedman of Washington on Wednesday. Hinckley’s underlying major depression and psychotic disorder are said to be in full remission, as they reportedly have been for the last twenty years.

As I have said before many times, mental illness is one of the two top causes of gun violence. The other is terrorism. Guns themselves are irrelevant. I believe John Hinckley would have used another potentially lethal weapon to try to kill President Reagan, when he was delusional and violent, had he not used a firearm.

Mental illnesses like Hinckley’s are more often than not, quite treatable, and it is entirely credible that the symptoms of his illness may now be gone and may never return.

Psychotherapy, combined with medications, can alleviate profound depression, bipolar disorder and many other conditions.

Good psychiatric treatment, made properly available, will beat gun control for preventing lethal or near-lethal violence, hands down, period.

Sadly, Hinckley’s treatment came after he wounded the President, shot Press Secretary James Brady in the head and shot two others.

Certainly, it would be foolish not to follow John Hinckley’s clinical condition carefully, being vigilant for any signs of a recurrence of his symptoms. And it is just as profoundly foolish that we have left our fragmented, sorry excuse for a mental health care system in ruins, with reprehensible cracks big enough for many ill and violent individuals to slip through—often, through no fault of their own.

Let me put it this way, just to underline my point: I would much rather allow John Hinckley to own a firearm while remaining under rigorous psychiatric treatment and monitoring, than I would to allow him to discontinue psychiatric treatment while remaining unarmed. (In his case, of course, we need not make the decision).

Good psychiatric treatment, made properly available, will beat gun control for preventing lethal or near-lethal violence, hands down, period.

Psychiatry can and does, routinely, cure men like John Hinckley. And it can also prevent events like the one that almost cost us one of the greatest presidents of all time.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bascom's $30.8M Vegas Refi Amid Market Hurdles

Updated Category News Views 103

Diving into the Vegas Real Estate Scene Alright, folks, let's roll up our sleeves and talk about something that's got my attention—Bascom Group's recent $30.8 million refinance of the Gateway Villas Apartments in Las Vegas. This ain't just another vanilla transaction in the back pages of some real estate journal. It's a play that screams strategy, especially in a world...

Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds

Updated Category News Views 54

A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...

Continue Reading
SK Bio Pushes FDA Approval for Cenobamate in Seizures

Updated Category News Views 66

Taking New Strides in Epilepsy Treatment Today, we’ve got SK Biopharmaceuticals banging on the FDA’s door with a pile of paperwork. They’re pushing for the green light on cenobamate to tackle primary generalized tonic-clonic (PGTC) seizures, plus expand its use to pediatric patients with the focal-onset seizure condition. Now, if you think it sounds like a big...

Continue Reading
Nomad Foods' Battle with Margins Amid Flat Volumes

Updated Category News Views 73

Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...

Continue Reading
Vehicle Reliability Hinges on Design and Maintenance

Updated Category News Views 25

Why Some Cars Age Like Fine Wine—and Some Don't Here’s the thing—cars aren’t all made equal, and anybody who's tinkered around under the hood for a few years long knows that some vehicles just can’t hold it together as time marches on. Now, this ain't rocket science, but the truth is wrapped up in the complexity of designs and those pesky little maintenance...

Continue Reading
Brazilian Jiu-Jitsu's Ground Game: Real-World Self-Defense

Updated Category News Views 55

From Mat to Reality: Brazilian Jiu-Jitsu's Claim to Fame It ain't all high kicks and flashy moves when it comes to self-defense, folks. Enter Brazilian Jiu-Jitsu (BJJ)—an art that's not just about show but about practical, gritty reality. Ever been curious why this discipline is hailed for self-defense? Wayne Marble, a seasoned martial arts expert, dishes out the why's...

Continue Reading
Doppel's Strategic Expansion: Adding PropRise Innovators

Updated Category News Views 46

Doppel Boosts Its Team with PropRise Founders The market doesn’t lie: when a company's on a roll, you watch it closely. Doppel's latest move is a serious signal. They've snagged PropRise, a sprightly Y Combinator graduate, and landed its founders, Jean-Michael Diei and Matthew Krager, right into their engineering fold. These guys aren't greenhorns—cutting their teeth...

Continue Reading
ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 64

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
Sentra Snags $150M to Shield Data in AI Era

Updated Category News Views 237

Agents in the Data Game Who would've thought data would need protection from its own minders? That's what Sentra's addressing with their smart pivot to 'agentic' data security. AI agents are out there gobbling data faster than a trader overdosing on coffee during a bull run. As AI's pace accelerates, Sentra spotted an opportunity to safeguard data from unauthorized eyes....

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 78

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading

Top 5 Most Recently Viewed Articles

FDA Priority Review: Precigen's Innovative Therapy for RRP

Updated Category News Views 399

FDA's Priority Review: A Game Changer for RRP Treatment The FDA has granted a priority review designation to Precigen, Inc. for its biologics license application (BLA) concerning PRGN-2012, a groundbreaking therapy targeting adults suffering from recurrent respiratory papillomatosis (RRP). This fast-tracked review reduces the evaluation timeline to just six months,...

Continue Reading
GCL Global Expands Influence through Ban Leong Acquisition Bid

Updated Category News Views 181

GCL Global's Strategic Move in the Gaming Industry Recently, GCL Global Holdings Ltd. (NASDAQ: GCL), a prominent entity in the entertainment sector, took a significant step by declaring its bid for Ban Leong Technologies Limited unconditional. This decision marks a pivotal moment for GCL and highlights its ambition to expand its reach within the gaming market. Key Aspects...

Continue Reading
Investors of Iris Energy Limited May Pursue Legal Action Now

Updated Category News Views 148

Investors of Iris Energy Limited Have a Legal Opportunity There's a significant opportunity for individuals who have invested in Iris Energy Limited (NASDAQ: IREN) to take action following allegations of securities fraud. The Rosen Law Firm, known for defending investor rights on a global scale, is urging those who purchased shares during a specified period to consider...

Continue Reading
Unveiling Exciting New Beauty Brands at QVC This Year

Updated Category News Views 169

Discover New Brands This Year at QVC As we step into a fresh year, QVC is excited to add vibrant new brands to its beauty and wellness collection, enhancing the self-care journey for its dedicated customers. This month, QVC introduces Love Wellness, No Makeup Makeup, and Gatineau Skincare – all set to redefine beauty routines. The Launch of Love Wellness Founded by Lo...

Continue Reading
Autodesk Executive's Significant Share Sale: Insights and Updates

Updated Category News Views 87

Insight into Autodesk Executive’s Share Sale Recently, Mary T. McDowell, a director at Autodesk, Inc. (NASDAQ: ADSK), sold 550 shares of the company's stock for $265.50 each. This sale brought in more than $146,000, as indicated in a filing with the Securities and Exchange Commission. The market closely watches these insider trades because they can offer clues about...

Continue Reading